comparemela.com

Latest Breaking News On - Apex level advisory committee - Page 1 : comparemela.com

Probing The Toll

Probing The Toll
kashmirlife.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kashmirlife.net Daily Mail and Mail on Sunday newspapers.

Alarming COVID-19 deaths in Jammu

Alarming COVID-19 deaths in Jammu   Figures of people succumbing to COVID virus show a trend of constant rapid rise despite comparatively better medical treatment available at hospitals and nonstop over two weeks corona curfew hindering human movement and business establishments fully shut. While the emerging scenario is definitely a cause of great concern, at the same time, pointedly knowing the reasons of such a surge and how to bring it under control is cardinal and paramount. At the outset, if the incubation period of the virus in its more lethal variant, in its victim is on the average said to be four days, 15 days corona curfew and most of the people confining themselves to a cloistered protection, the rate of fresh infections and the resultant deaths should have been declining. Since the mystery of such a colossal loss of human lives can precisely be unravelled by medical experts only, however, Apex Level Advisory Committee has maintained that majority of the variants of th

Why Is Jammu Reporting More Covid19 Deaths Despite Low Infection Rate?

SRINAGAR: Three top Kashmir doctors who were flown to Jammu for discussions with doctors and understand the factors responsible for high mortality have submitted a detailed report. They have had interactions with the GMC Jammu principle and all the relevant heads of the departments for an assessment to understand the trend. Government Medical College, Jammu “This is slightly complex and we have conveyed it to the government,” one of the three top experts, told Kashmir Life on phone, moments after the interactions were over on Wednesday afternoon. “The health infra is too much centralised in Jammu and then there are a lot of cultural issues in which patients prefer hospital as the last option.”

Apex Committee unravels mystery behind maximum COVID-19 deaths in Jammu

Says majority of variants more prevalent in this part of UT Mohinder Verma JAMMU, May 12: Unraveling the mystery behind maximum COVID-19 related deaths in Jammu province during the 2021 surge, Apex Level Advisory Committee has pointed out that majority of the variants of the disease and Indian Double Mutant are more prevalent in this part of the Union Territory as compared to Kashmir region because of several reasons. Accordingly, it has suggested that strict enforcement of COVID appropriate behavior and intensification of vaccination drive are imperative steps to effectively fight the surge and control the prevailing worrisome situation. Quoting the findings of the Apex Level Advisory Committee, official sources told EXCELSIOR that of the 306 samples sent from Government Medical College Jammu, sequences from 228 samples had been generated and the reasons for the inability to sequence other samples included either poor quality of samples or insufficient volume of the samples.

Several COVID variants circulating in J&K UT population, to further show increased infectivity

Make negative RT-PCR report mandatory for all travellers Mohinder Verma JAMMU, May 11: Observing that SARS CoV-2 viruses in Jammu and Kashmir have shown significant mutations and several variants which are circulating in the population of the Union Territory will further show increased infectivity in the coming days, Apex Level Advisory Committee has suggested an Action Plan to the Government to effectively fight the surge in the pandemic. The Apex Level Advisory Committee headed by Prof Mohammad Sultan Khuroo, former Dean and Director SKIMS and comprising of medical experts from both the regions of the Union Territory of Jammu and Kashmir was constituted last year to review the protocol, guidelines and other related issues about the treatment of COVID-19 patients and their implementation.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.